... boasts over 100 years of combined experience across the value chain, continuously pioneering the German cannabis market.
Daniel Kruse, a pioneer in the hemp industry since 1995, serves as Managing Director (CEO) of SYNBIOTIC SE and is the founder of Hempro International GmbH, Hemp Factory GmbH, MH medical hemp GmbH, Hemp Farm GmbH, and HempConsult GmbH - five of Europe's leading hemp companies. Since 2013, Daniel Kruse has served as a board member of the European Industrial Hemp Association (EIHA) and was elected president in 2019. Additionally, Kruse also serves as vice chairman of the Federation of International Hemp Organizations (FIHO).
Rebecca Kruse has been working for Hempro International in the marketing department and product development since completing her studies in economics in 2006. As a trained businesswoman, she has amassed valuable experience in the corporate world and the international hemp market over the years, making her an expert in all aspects of brand management and product positioning. Additionally, she has focused on finances, internal organisation, and communication. Rebecca is a specialist in controlling, data analysis, and process optimisation. She served as Managing Director of Hempro Int. and Hemp Factory for many years. Since 2023, Rebecca has held the position of Head of Finance at SYNBIOTIC SE.
As a tax specialist, she has been with Solidmind Group GmbH and Lean Labs Pharma GmbH since 2018. She joined the management team at the group level in the Finance & Controlling department in early 2023. Her responsibilities include preparing consolidated financial statements, handling all reporting, and managing liquidity planning.
Holder of a Master´s in Business Administration/Management with over 10 years of experience in sales, marketing, business development and restructuring. Since 2019, employed in the cannabis industry at Solidmind Group GmbH as a member of the management board. From 2023, part of the management team at SYNBIOTIC SE with a focus on projects and synergies, developing new business concepts, and overseeing the ventures Solidmind Group GmbH and Cannexo GmbH.
Lukas is a banking specialist with a bachelor's degree in business administration/management. Since 2016, he has served as manager of Solidmind Group GmbH and Lean Labs Pharma GmbH, holding positions as an authorized representative and COO. Since spring 2023, Lukas has a part of the management team at the group level in the Projects & Synergies department. His responsibilities include managing research and development projects as well as synergistically consolidating various investments.
With over a decade of experience as a business and marketing leader, including building one of Germany's largest financial communities, he joined the management of SYNBIOTIC SE in 2021. Responsible for internal and external communications, he focuses on developing, retaining, and expanding the company's network.
Steuerfachwirtin, seit 2018 bei der Solidmind Group GmbH und Lean Labs Pharma GmbH. Seit Frühjahr 2023 im Management Team auf Konzernebene im Bereich Finance & Controlling. Zu ihren Aufgaben zählt die Erstellung des Konzernabschlusses, sämtliches Reporting sowie die Liquiditätsplanung.
Master in Betriebswirtschaft/Management, über 10 Jahre Fachexpertise in Sales, Marketing, Business Development und Restrukturierung. Seit 2019 in der Cannabis Branche bei der Solidmind Group GmbH als Mitglied der Geschäftsführung. Ab 2023 im Management Team der SynBiotic SE mit Fokus auf Projekte und Synergien, New Business Konzepte und Management der Beteiligungen Solidmind Group GmbH und Cannexo GmbH.
Bankkaufmann und Bachelor in Betriebswirtschaft/Management. Seit 2016 Führungskraft der Solidmind Group GmbH und der Lean Labs Pharma GmbH als Prokurist und COO. Seit Frühjahr 2023 im Management-Team auf Konzernebene im Bereich Projekte & Synergien. Zu seinen Aufgaben zählt die Leitung der Forschung- und Entwicklungsprojekte sowie die synergetische Zusammenführung der verschiedenen Beteiligungen.
Mit über einem Jahrzehnt Erfahrung als Unternehmer und Marketing Leader und dem Aufbau einer der größten Finanz Communities in Deutschland, trat er 2021 dem Management von SynBiotic SE bei. In seiner Rolle ist er verantwortlich für interne und externe Kommunikation sowie für die Entwicklung, Erhaltung und Erweiterung des Netzwerks der Gruppe.
As a tax specialist, she has been with Solidmind Group GmbH and Lean Labs Pharma GmbH since 2018. She joined the management team at the group level in the Finance & Controlling department in early 2023. Her responsibilities include preparing consolidated financial statements, handling all reporting, and managing liquidity planning.
Holder of a Master´s in Business Administration/Management with over 10 years of experience in sales, marketing, business development and restructuring. Since 2019, employed in the cannabis industry at Solidmind Group GmbH as a member of the management board. From 2023, part of the management team at SynBiotic SE with a focus on projects and synergies, developing new business concepts, and overseeing the ventures Solidmind Group GmbH and Cannexo GmbH.
Lukas is a banking specialist with a bachelor's degree in business administration/management. Since 2016, he has served as manager of Solidmind Group GmbH and Lean Labs Pharma GmbH, holding positions as an authorized representative and COO. Since spring 2023, Lukas has a part of the management team at the group level in the Projects & Synergies department. His responsibilities include managing research and development projects as well as synergistically consolidating various investments.
With over a decade of experience as a business and marketing leader, including building one of Germany's largest financial communities, he joined the management of SynBiotic SE in 2021. Responsible for internal and external communications, he focuses on developing, retaining, and expanding the company's network.
Oliver Conrad, Managing Partner at AHW Hunold & Partner in Cologne since 2023. Certified tax advisor since 2014, appointed auditor in 2015. Specialises in national and international accounting, due diligence, financial process optimisation, risk management, tax compliance, annual audit, company valuation, and special economic audit. Member of IDW, Chamber of Auditors, and Chamber of Tax Advisors NRW. Experienced in biotechnology, pharmaceutical industry, chemicals, aviation, trade, and services. Previously worked at a Big Four firm as a director.
Rainer Seiler is a healthcare market consultant and entrepreneur. He develops and implements value-creating business models, procurement projects, and selective contracts, primarily in the pharmaceutical sector. Currently, he supports international companies in Market Access, Sales and Digital Health, bringing extensive industry experience to several healthcare companies. With 20 years of leadership experience in pharmaceuticals, pharmacies, eCommerce, and wholesale, including as Managing Director at the Swiss Zur Rose Group (including DocMorris), he has authored professional books covering topics such as patient centricity, healthcare innovation, and managed care. He is also active in various health-related organisations, including as a co-founder of the non-profit initiative Pflasterpass, dedicated to providing first aid for children.
Frank Otto is a German multi-entrepreneur and a major shareholder of SYNBIOTIC SE through his investment in CannaCare Health GmbH. With many years of experience in the media business, he is a co-founder of various companies in the healthcare market. Frank Otto has been actively involved in environmental and social projects in Hamburg and pursues the goal of linking economic success with sustainable action, especially in the field of cannabis.
Bruce Linton is the founder and former CEO and Chairman of Canopy Growth Corporation, one of the world's largest cannabis-focused companies. Bruce Linton is currently a member of the board of Creso Pharma, co-chairman and former CEO of Martello Technologies Group Inc. and chairman of the advisory board of Red Light Holland Corp. He is also an advisor to Celadon Pharmaceuticals and Above Foods.
Dr. Thomas Haffner has over 25 years of experience in the pharmaceutical industry, particularly in product development and international licensing. He is a leading expert in the conception and marketing of over-the-counter (OTC) drugs, project management, and consulting for successful drug manufacturers.